JPWO2019150119A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2019150119A5
JPWO2019150119A5 JP2020541791A JP2020541791A JPWO2019150119A5 JP WO2019150119 A5 JPWO2019150119 A5 JP WO2019150119A5 JP 2020541791 A JP2020541791 A JP 2020541791A JP 2020541791 A JP2020541791 A JP 2020541791A JP WO2019150119 A5 JPWO2019150119 A5 JP WO2019150119A5
Authority
JP
Japan
Prior art keywords
methyl
hydroxy
azaspiro
decane
carbonyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020541791A
Other languages
English (en)
Japanese (ja)
Other versions
JP7464526B2 (ja
JP2021525220A (ja
Publication date
Priority claimed from GBGB1801562.8A external-priority patent/GB201801562D0/en
Application filed filed Critical
Publication of JP2021525220A publication Critical patent/JP2021525220A/ja
Publication of JPWO2019150119A5 publication Critical patent/JPWO2019150119A5/ja
Application granted granted Critical
Publication of JP7464526B2 publication Critical patent/JP7464526B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020541791A 2018-01-31 2019-01-31 4-ヒドロキシピペリジン誘導体およびユビキチン特異的プロテアーゼ19(usp19)の阻害剤としてのその使用 Active JP7464526B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1801562.8 2018-01-31
GBGB1801562.8A GB201801562D0 (en) 2018-01-31 2018-01-31 Pharmaceutical compounds
PCT/GB2019/050271 WO2019150119A1 (en) 2018-01-31 2019-01-31 4-hydroxypiperidine derivatives and their use as inhibitors of ubiquitin specific protease 19 (usp19)

Publications (3)

Publication Number Publication Date
JP2021525220A JP2021525220A (ja) 2021-09-24
JPWO2019150119A5 true JPWO2019150119A5 (hr) 2022-02-02
JP7464526B2 JP7464526B2 (ja) 2024-04-09

Family

ID=61558043

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020541791A Active JP7464526B2 (ja) 2018-01-31 2019-01-31 4-ヒドロキシピペリジン誘導体およびユビキチン特異的プロテアーゼ19(usp19)の阻害剤としてのその使用

Country Status (16)

Country Link
US (1) US11807646B2 (hr)
EP (1) EP3746432B1 (hr)
JP (1) JP7464526B2 (hr)
KR (1) KR20200115623A (hr)
CN (1) CN112135818A (hr)
AU (1) AU2019213562A1 (hr)
BR (1) BR112020015449A2 (hr)
CA (1) CA3089538A1 (hr)
ES (1) ES2934958T3 (hr)
GB (1) GB201801562D0 (hr)
IL (1) IL276324A (hr)
MX (1) MX2020008091A (hr)
RU (1) RU2020127848A (hr)
SG (1) SG11202007179SA (hr)
WO (1) WO2019150119A1 (hr)
ZA (1) ZA202004909B (hr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220016115A1 (en) * 2018-12-06 2022-01-20 Almac Discovery Limited Usp19 inhibitors for use in therapy
KR20210102285A (ko) * 2018-12-06 2021-08-19 알막 디스커버리 리미티드 약학적 화합물 및 유비퀴틴 특이적 단백질분해효소 19 (usp19)의 억제제로서의 사용
GB202104097D0 (en) 2021-03-24 2021-05-05 Almac Discovery Ltd Pharmaceutical compounds

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO111096A0 (en) 1996-07-18 1996-08-08 Fujisawa Pharmaceutical Co., Ltd. New compound
ES2309206T3 (es) 2001-10-02 2008-12-16 Smithkline Beecham Corporation Compuestos quimicos.
FR2873691B1 (fr) 2004-07-29 2006-10-06 Sanofi Synthelabo Derives d'amino-piperidine, leur preparation et leur application en therapeutique
EP2565186A1 (en) 2011-09-02 2013-03-06 Hybrigenics S.A. Selective and reversible inhibitors of ubiquitin specific protease 7
MA41291A (fr) * 2014-12-30 2017-11-07 Forma Therapeutics Inc Dérivés de la pyrrolotriazinone et de l'imidazotriazinone en tant qu'inhibiteurs de la protéase spécifique de l'ubiquitine n° 7 (usp7) pour le traitement d'un cancer
TWI698436B (zh) * 2014-12-30 2020-07-11 美商佛瑪治療公司 作為泛素特異性蛋白酶7抑制劑之吡咯并及吡唑并嘧啶
EP3253759A1 (en) * 2015-02-05 2017-12-13 Forma Therapeutics, Inc. Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimidinones as ubiquitin-specific protease 7 inhibitors
WO2016126926A1 (en) * 2015-02-05 2016-08-11 Forma Therapeutics, Inc. Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors
US9932351B2 (en) * 2015-02-05 2018-04-03 Forma Therapeutics, Inc. Thienopyrimidinones as ubiquitin-specific protease 7 inhibitors
FR3052452B1 (fr) 2016-06-10 2018-06-22 Les Laboratoires Servier Nouveaux derives de piperidinyle, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
PE20220948A1 (es) 2016-06-10 2022-05-31 Servier Lab Nuevos derivados piperidinilo sustituidos con (hetero) arilo, un proceso para su preparacion y composiciones farmaceuticas que los contienen
GB201612938D0 (en) * 2016-07-26 2016-09-07 Almac Discovery Ltd Pharmaceutical compounds
GB201617758D0 (en) 2016-10-20 2016-12-07 Almac Discovery Limited Pharmaceutical compounds
KR20210102285A (ko) * 2018-12-06 2021-08-19 알막 디스커버리 리미티드 약학적 화합물 및 유비퀴틴 특이적 단백질분해효소 19 (usp19)의 억제제로서의 사용

Similar Documents

Publication Publication Date Title
AU2017277732B2 (en) New (hetero)aryl-substituted-piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them
AU2018201903B2 (en) SUBSTITUTED N-(1H-INDAZOL-4-YL)IMIDAZO[1,2-a]PYRIDINE-3-CARBOXAMIDE COMPOUNDS AS TYPE III RECEPTOR TYROSINE KINASE INHIBITORS
KR101812357B1 (ko) Cdk4/6의 억제제로서의 피롤로피리미딘 화합물
KR101659193B1 (ko) Btk 활성의 억제제로서의 헤테로아릴 피리돈 및 아자-피리돈 화합물
JP6123804B2 (ja) 3環性ヘテロ環化合物及びjak阻害剤
HRP20120105T1 (hr) Aminoheterociklički spojevi
JP2019535664A5 (hr)
JP2016525092A5 (hr)
US20200172546A1 (en) Pyrazolo[3,4-b]pyrazine derivatives as shp2 phosphatase inhibitors
JP2018500376A5 (hr)
JP2021506858A5 (hr)
US20220289753A1 (en) Shp2 inhibitors
JP2014506929A5 (hr)
HRP20230086T1 (hr) Inhibitori lizin specifične demetilaze-1
HRP20160649T1 (hr) Novi derivati tienopirimidina, postupci za njihovo pripremanje i njihova terapeutska uporaba
WO2017059191A1 (en) Heteroaryl derivatives as sepiapterin reductase inhibitors
JP2011511034A5 (hr)
JP2013523884A (ja) JAKキナーゼの阻害剤としての5,7置換イミダゾ[1,2−c]ピリミジン
JP2017518326A5 (hr)
RU2020127848A (ru) Производные 4-гидроксипиперидина и их применение в качестве ингибиторов убиквитин-специфической протеазы 19 (usp19)
JP2021504380A5 (hr)
AU2021370660A1 (en) Heterocyclic spiro compounds and methods of use
JP2019502680A5 (hr)
JPWO2019150119A5 (hr)
JPWO2020115501A5 (hr)